CIK 0001607678 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 0 | 0 |
| Net income (USD) | -359.6 M | -68.9 M |
| Diluted EPS (USD/shares) | -3.19 | -0.9 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-28 | 8-K | 8-K items 1.01,2.03,9.01 | 2026-09-23 |
| 2026-09-25 | 424B5 | 424B5 | |
| 2026-09-25 | 424B5 | 424B5 | |
| 2026-09-24 | FWP | FREE WRITING PROSPECTUS | |
| 2026-09-24 | 305B2 | APPLICATION FOR DESIGNATION OF A NEW TRUSTEE | |
| 2026-09-23 | 424B5 | 424B5 | |
| 2026-09-23 | 424B5 | 424B5 | |
| 2026-09-22 | 8-K | 8-K items 8.01,9.01 | 2026-09-22 |
| 2026-08-07 | 4 | 4 | 2026-08-01 |
| 2026-08-07 | 3 | 3 | 2026-08-01 |
| 2026-07-30 | S-3ASR | S-3ASR | |
| 2026-07-29 | 4 | 4 | 2026-07-28 |
| 2026-07-29 | 4 | 4 | 2026-07-28 |
| 2026-07-29 | 4 | 4 | 2026-07-28 |
| 2026-07-29 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-29 | 144 | 144 | |
| 2026-07-29 | 8-K | 8-K items 2.02,9.01 | 2026-07-29 |
| 2026-07-29 | 144 | 144 | |
| 2026-07-29 | 144 | 144 | |
| 2026-06-03 | 4 | 4 | 2026-06-01 |
| 2026-06-03 | 3 | 3 | 2026-06-01 |
| 2026-05-26 | 8-K | 8-K items 5.07,9.01 | 2026-05-19 |
| 2026-04-30 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-04-30 | 10-Q | 10-Q | 2026-03-31 |
| 2026-04-29 | 8-K | 8-K items 2.02,9.01 | 2026-04-29 |
Forms on file (last 1,000): 4 195, 8-K 109, 144 50, 10-Q 35, SC 13G/A 28, CORRESP 26, 424B5 20, 3 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VKTX (0.002 USD), /gw/filings/filings?ticker=VKTX&form=8-K, /gw/filings/facts?ticker=VKTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange